Dermatology

Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.

Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

After five years, the probability of remaining free from treatment failure was 77.8% for patients who underwent superficial curettage.

While numerous pharmacological treatments for atopic dermatitis exist, there is a scarcity of effective nonpharmacological interventions.

A targeted rituximab infusion at 6 months, based on relapse predictors, significantly reduced pemphigus recurrence at one year.

Neoadjuvant T-VEC achieves resectability in 50% of difficult-to-treat BCC cases, improving outcomes without extensive reconstructive surgery.

Studies have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with gastrointestinal discomfort.

Diabetes was investigated in five studies, with only one demonstrating a correlation between the condition and higher hospital readmission rates.